Optimizing de-escalation of inhaled corticosteroids in COPD: a systematic review of real-world findings-Reference-Cited by-同舟云学术

Optimizing de-escalation of inhaled corticosteroids in COPD: a systematic review of real-world findings

Published:2020-09-01 Issue:9 Volume:13 Page:977-990
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Rogliani Paola¹^ORCID,Ritondo Beatrice Ludovica¹,Gabriele Mariachiara¹,Cazzola Mario¹^ORCID,Calzetta Luigino²^ORCID

Affiliation:

1. Department of Experimental Medicine, University of Rome “Tor Vergata”, Rome, Italy

2. Department of Medicine and Surgery, Respiratory Disease and Lung Function Unit, University of Parma, Parma, Italy

Funder

Boehringer Ingelheim Italia

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2020.1817739

Reference52 articles.

1. GOLD. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of COPD – 2020 report; 2020 [cited 2020 Apr 22]. Available from: https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf

2. Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD

3. Withdrawal of inhaled corticosteroids in people with COPD in primary care: a randomised controlled trial

4. Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial

5. Effect of Discontinuation of Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV-associated lung disease;Nature Reviews Disease Primers;2023-07-27

2. Assessment of primary care provider and pharmacist knowledge, comfort, and barriers to appropriate inhaled corticosteroid use in chronic obstructive pulmonary disease;JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY;2023-01-11

3. De-Prescribing Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: A Narrative Review;Journal of Pharmacy Practice;2022-12-02

4. Pharmacotherapy of LAMA/LABA inhaled therapy combinations for chronic obstructive pulmonary disease: a clinical overview;Expert Review of Clinical Pharmacology;2022-11-02

5. Advances in inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease: what is their value today?;Expert Opinion on Pharmacotherapy;2022-05-22